First Time Loading...

Transgene SA
PAR:TNG

Watchlist Manager
Transgene SA Logo
Transgene SA
PAR:TNG
Watchlist
Price: 1.328 EUR -0.6% Market Closed
Updated: May 17, 2024

Transgene SA
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Transgene SA
Cash from Operating Activities Peer Comparison

Comparables:
VLA
NANO
IPH
ALCLS
ABVX

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Transgene SA
PAR:TNG
Cash from Operating Activities
-€34.7m
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
4%
Valneva SE
PAR:VLA
Cash from Operating Activities
-€202.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-26%
Nanobiotix SA
PAR:NANO
Cash from Operating Activities
-€12.5m
CAGR 3-Years
23%
CAGR 5-Years
14%
CAGR 10-Years
-6%
Innate Pharma SA
PAR:IPH
Cash from Operating Activities
-€32.6m
CAGR 3-Years
14%
CAGR 5-Years
0%
CAGR 10-Years
-11%
Cellectis SA
PAR:ALCLS
Cash from Operating Activities
-$24.7m
CAGR 3-Years
32%
CAGR 5-Years
18%
CAGR 10-Years
0%
Abivax SA
PAR:ABVX
Cash from Operating Activities
-€97.1m
CAGR 3-Years
-48%
CAGR 5-Years
-46%
CAGR 10-Years
N/A

See Also

What is Transgene SA's Cash from Operating Activities?
Cash from Operating Activities
-34.7m EUR

Based on the financial report for Dec 31, 2023, Transgene SA's Cash from Operating Activities amounts to -34.7m EUR.

What is Transgene SA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
4%

Over the last year, the Cash from Operating Activities growth was -71%. The average annual Cash from Operating Activities growth rates for Transgene SA have been -6% over the past three years , -4% over the past five years , and 4% over the past ten years .